PEDIATRIC VACCINE STOCKPILES - PowerPoint PPT Presentation

1 / 8
About This Presentation
Title:

PEDIATRIC VACCINE STOCKPILES

Description:

PEDIATRIC VACCINE STOCKPILES A Status Report on the Pediatric Vaccine Stockpiles November 2005 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Program Support Branch (PSB) – PowerPoint PPT presentation

Number of Views:42
Avg rating:3.0/5.0
Slides: 9
Provided by: NIP1
Category:

less

Transcript and Presenter's Notes

Title: PEDIATRIC VACCINE STOCKPILES


1
PEDIATRIC VACCINE STOCKPILES
  • A Status Report on the Pediatric Vaccine
    Stockpiles
  • November 2005

Gregory S. Wallace, M.D., M.S., M.P.H. Chief,
Program Support Branch (PSB) Immunization
Services Division (ISD) National Immunization
Program (NIP)
2
History
  • 1983 Began stockpiling pediatric vaccines
  • 1993 VFC legislation enacted established
    requirement for 6-month stockpile of all
    routinely recommended childhood vaccines
  • 1993 Began purchasing vaccines for stockpile
  • 2002 Revenue recognition issues arise
  • 2005 All vaccine manufacturers agree to sell
    vaccines to CDC for stockpile

3
Pediatric Vaccine Stockpiles
  • What happened?
  • May 2005 - CDC met with SEC
  • June-July 2005 - SEC met with the corporate HQs
    of all four vaccine manufacturers
  • August 2005 - All of the vaccine manufacturers
    agreed to participate in the CDC Pediatric
    Vaccine Stockpile Program
  • Regardless of the revenue recognition issues
  • Based on their capacity to sell CDC vaccines for
    the stockpile

4
Pediatric Vaccine Stockpiles
  • Fiscal Year (FY) 2005 activity
  • All four manufacturers agreed in FY 2005 to sell
    vaccine to CDC for the Pediatric Vaccine
    Stockpiles
  • 158.8M obligated to purchase 5,500 doses
  • CDC established new target quantities for
    stockpiled vaccine
  • CDC established revised plans for future vaccine
    purchases for the stockpile

5
Pediatric Vaccine StockpilesCurrent Status
6
Purchased/Undelivered Doses
  • FY 2003
  • 2.4 million doses IPV (sanofi)
  • 2 million doses HepB (GSK)
  • 1 million doses HepA (GSK)
  • 0.8 million doses PCV7 (Wyeth)
  • FY 2005
  • 0.5 million doses Hib (sanofi)
  • 1.5 million doses DTaP (sanofi GSK)
  • 2 million doses PCV7 (Wyeth)
  • 0.5 million doses DTaP/HepB/IPV

7
Pediatric Vaccine Stockpiles
  • Stockpile management
  • Target quantities workgroup
  • NVAC ACIP participation
  • Contract review and revision
  • Purchase vs. delivery price
  • Third-party distributor

8
Next Steps
  • Review and revise contracts with two (2)
    manufacturers who have existing stockpile
    contracts
  • Establish new stockpile contracts with two(2)
    vaccine manufacturers
  • Incorporate stockpile management into VMBIP
Write a Comment
User Comments (0)
About PowerShow.com